ConductScience.org, home

Paper35948006

Discovery of compounds that reactivate p53 mutants in vitro and in vivo.

Durairaj G and 21 others. Cell Chem Biol, 2022. Cited by 30 papers, by iCite.

Cite this record

ConductScience Library. Discovery of compounds that reactivate p53 mutants in vitro and in vivo. Papers, record 35948006. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35948006

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Discovery of compounds that reactivate p53 mutants in vitro and in vivo.
PubMed
Journal
Cell Chem Biol
PubMed
Year
2022
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
30
iCite
Relative citation ratio, by iCite
2.13
iCite
Revised in PubMed
2024-09-23
PubMed

Authors22

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Durairaj GGeetha
2Demir ÖÖzlem
3Lim BBryant
4Baronio RRoberta
5Tifrea DDelia
6Hall LVLinda V
7DeForest JCJacob C
8Lauinger LLinda
9Jebril Fallatah MMMaryam M
10Yu CClinton
11Bae HHosung
12Lin DWDa-Wei
13Kim JKJin Kwang
14Salehi FFaezeh
15Jang CCholsoon
16Qiao FFeng
17Lathrop RHRichard H
18Huang LLan
19Edwards RRobert
20Rychnovsky SScott

Source PubMed

See all 22 authorsDownload CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
NeoplasmsMajor topic
Tumor Suppressor Protein p53Major topic
Cell Line, Tumor
Chromatin
DNA
Humans
Mutation
Protein Domains

Source PubMed

Download CSV of topics

Grants6

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R21 NS063874NINDS NIH HHSUnited StatesR21NS063874PubMed and NIHNIH RePORTER
R21 CA267495NCI NIH HHSUnited StatesR21CA267495PubMed and NIHNIH RePORTER
R01 GM132826NIGMS NIH HHSUnited StatesR01GM132826PubMed and NIHNIH RePORTER
R01 CA112560NCI NIH HHSUnited StatesR01CA112560PubMed and NIHNIH RePORTER
UL1 TR001414NCATS NIH HHSUnited StatesUL1TR001414PubMed and NIHNIH RePORTER
P30 CA062203NCI NIH HHSUnited StatesP30CA062203PubMed and NIHNIH RePORTER

Download CSV of grants

References44

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123161690The TP53 website: an integrative resource centre for the TP53 mutation database and TP53 mutant analysis.Nucleic Acids Res2013https://conductscience.org/library/papers/23161690PubMed
217251932Restoration of p53 function leads to tumour regression in vivo.Nature2007https://conductscience.org/library/papers/17251932PubMed
317538933Restoration of p53 function: a new therapeutic strategy to induce tumor regression?Hepatology2007https://conductscience.org/library/papers/17538933PubMed
420581117All-codon scanning identifies p53 cancer rescue mutations.Nucleic Acids Res2010https://conductscience.org/library/papers/20581117PubMed
525075903Improved vectors and genome-wide libraries for CRISPR screening.Nat Methods2014https://conductscience.org/library/papers/25075903PubMed
624157548Genome engineering using the CRISPR-Cas9 system.Nat Protoc2013https://conductscience.org/library/papers/24157548PubMed
717182091Modeling the therapeutic efficacy of p53 restoration in tumors.Cell2006https://conductscience.org/library/papers/17182091PubMed
830157040RITA induces apoptosis in p53-null K562 leukemia cells by inhibiting STAT5, Akt, and NF-κB signaling pathways.Anticancer Drugs2018https://conductscience.org/library/papers/30157040PubMed
933357454Arsenic Trioxide Rescues Structural p53 Mutations through a Cryptic Allosteric Site.Cancer Cell2021https://conductscience.org/library/papers/33357454PubMed
1011875500Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound.Nat Med2002https://conductscience.org/library/papers/11875500PubMed
1129576531Copper-Binding Small Molecule Induces Oxidative Stress and Cell-Cycle Arrest in Glioblastoma-Patient-Derived Cells.Cell Chem Biol2018https://conductscience.org/library/papers/29576531PubMed
1227806324PRIMA-1Met suppresses colorectal cancer independent of p53 by targeting MEK.Oncotarget2016https://conductscience.org/library/papers/27806324PubMed
1323360998Computational identification of a transiently open L1/S3 pocket for reactivation of mutant p53.Nat Commun2013https://conductscience.org/library/papers/23360998PubMed
1415861488NMR investigation of hydrogen bonding and 1,3-tautomerism in 2-(2-hydroxy-5-substituted-aryl) benzimidazoles.Magn Reson Chem2005https://conductscience.org/library/papers/15861488PubMed
1534862374Structural basis of reactivation of oncogenic p53 mutants by a small molecule: methylene quinuclidinone (MQ).Nat Commun2021https://conductscience.org/library/papers/34862374PubMed
1623828940Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay.Science2013https://conductscience.org/library/papers/23828940PubMed
1729125602Mechanisms of transcriptional regulation by p53.Cell Death Differ2018https://conductscience.org/library/papers/29125602PubMed
1819693097When mutants gain new powers: news from the mutant p53 field.Nat Rev Cancer2009https://conductscience.org/library/papers/19693097PubMed
1922624712Allele-specific p53 mutant reactivation.Cancer Cell2012https://conductscience.org/library/papers/22624712PubMed
2027533246Sensitivity to PRIMA-1MET is associated with decreased MGMT in human glioblastoma cells and glioblastoma stem cells irrespective of p53 status.Oncotarget2016https://conductscience.org/library/papers/27533246PubMed

See all 44 referencesDownload CSV of references

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 30 citations.

PMIDTitleJournalYearIn PapersSource
42598159Association between the expression of GSTP1 and mutant p53, poor chemotherapy response and metastasis in patients with osteosarcoma.Oncol Lett2026https://conductscience.org/library/papers/42598159PubMed
41279808Towards In Situ Dynamics of DNA-bound Full-Length p53 Tetramer.bioRxiv2025https://conductscience.org/library/papers/41279808PubMed
40729059Molecular Docking and Dynamic Studies of Chlorogenic Acid Isomers as Antagonists of p53 Transcription Factor for Potential Adjuvant Radiotherapy.Asian Pac J Cancer Prev2025https://conductscience.org/library/papers/40729059PubMed
40597785The complex journey of targeting RAS in oncology.BMC Cancer2025https://conductscience.org/library/papers/40597785PubMed
40116283Computational studies on the functional and structural impact of pathogenic mutations in enzymes.Protein Sci2025https://conductscience.org/library/papers/40116283PubMed
39930134Natural compound PEITC inhibits gain of function of p53 mutants in cancer cells by switching YAP-binding partners between p53 and p73.Acta Pharmacol Sin2025https://conductscience.org/library/papers/39930134PubMed
39450536TP53 mutations in cancer: Molecular features and therapeutic opportunities (Review).Int J Mol Med2025https://conductscience.org/library/papers/39450536PubMed
39199355Pyrimidine Triones as Potential Activators of p53 Mutants.Biomolecules2024https://conductscience.org/library/papers/39199355PubMed
39185441A novel heuristic of rigid docking scores positively correlates with full-length nuclear receptor LRH-1 regulation.Comput Struct Biotechnol J2024https://conductscience.org/library/papers/39185441PubMed
38862470Structural basis of p53 inactivation by cavity-creating cancer mutations and its implications for the development of mutant p53 reactivators.Cell Death Dis2024https://conductscience.org/library/papers/38862470PubMed
38396641Most Monogenic Disorders Are Caused by Mutations Altering Protein Folding Free Energy.Int J Mol Sci2024https://conductscience.org/library/papers/38396641PubMed
38358129Toward physics-based precision medicine: Exploiting protein dynamics to design new therapeutics and interpret variants.Protein Sci2024https://conductscience.org/library/papers/38358129PubMed
38018912Characterization on the oncogenic effect of the missense mutations of p53 via machine learning.Brief Bioinform2023https://conductscience.org/library/papers/38018912PubMed
37373306Identifying the Molecular Drivers of Pathogenic Aldehyde Dehydrogenase Missense Mutations in Cancer and Non-Cancer Diseases.Int J Mol Sci2023https://conductscience.org/library/papers/37373306PubMed
36965249On the linkage of thermodynamics and pathogenicity.Curr Opin Struct Biol2023https://conductscience.org/library/papers/36965249PubMed
36964053Small-molecule correctors and stabilizers to target p53.Trends Pharmacol Sci2023https://conductscience.org/library/papers/36964053PubMed
36859359Targeting p53 pathways: mechanisms, structures, and advances in therapy.Signal Transduct Target Ther2023https://conductscience.org/library/papers/36859359PubMed

Download CSV of cited by

Genes18

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ANXA5308PubTator's text mininghttps://conductscience.org/library/genes/308NCBI Gene
BBC327113PubTator's text mininghttps://conductscience.org/library/genes/27113NCBI Gene
DICER123405PubTator's text mininghttps://conductscience.org/library/genes/23405NCBI Gene
GADD45A1647PubTator's text mininghttps://conductscience.org/library/genes/1647NCBI Gene
GAPDH2597PubTator's text mininghttps://conductscience.org/library/genes/2597NCBI Gene
H3P16644914PubTator's text mininghttps://conductscience.org/library/genes/644914NCBI Gene
HDAC99734PubTator's text mininghttps://conductscience.org/library/genes/9734NCBI Gene
KAT6A7994PubTator's text mininghttps://conductscience.org/library/genes/7994NCBI Gene
KMT2A4297PubTator's text mininghttps://conductscience.org/library/genes/4297NCBI Gene
MYC4609PubTator's text mininghttps://conductscience.org/library/genes/4609NCBI Gene
PMAIP15366PubTator's text mininghttps://conductscience.org/library/genes/5366NCBI Gene
PRIMA1145270PubTator's text mininghttps://conductscience.org/library/genes/145270NCBI Gene
SENP326168PubTator's text mininghttps://conductscience.org/library/genes/26168NCBI Gene
SUMO17341PubTator's text mininghttps://conductscience.org/library/genes/7341NCBI Gene
TP537157PubTator's text mininghttps://conductscience.org/library/genes/7157NCBI Gene
TP638626PubTator's text mininghttps://conductscience.org/library/genes/8626NCBI Gene
TP737161PubTator's text mininghttps://conductscience.org/library/genes/7161NCBI Gene
XPO17514PubTator's text mininghttps://conductscience.org/library/genes/7514NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35948006

GET https://conductscience.org/api/papers/v1/35948006/authors?page=2